Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients (Q37374502)

20 August 2017

Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients (English)

1 reference

enzyme replacement therapy

20 August 2017

0 references

mucopolysaccharidosis I

1 reference

Moin Vera

1

1 reference

20 August 2017

Steven Le

2

1 reference

20 August 2017

Shih-Hsin Kan

3

1 reference

20 August 2017

Hermes Garban

4

1 reference

20 August 2017

David Naylor

5

1 reference

20 August 2017

Anton Mlikotic

6

1 reference

20 August 2017

Ilkka Kaitila

7

1 reference

20 August 2017

Paul Harmatz

8

1 reference

20 August 2017

Agnes Chen

9

1 reference

20 August 2017

Patricia Dickson

10

1 reference

20 August 2017

language of work or name

English

0 references

publication date

3 September 2013

1 reference

20 August 2017

1 reference

20 August 2017

74

1 reference

20 August 2017

6

1 reference

20 August 2017

712-720

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2013.158

20 August 2017

0 references

cites work

Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Original Papers: ON FROIN'S SYNDROME, AND ITS RELATION TO ALLIED CONDITIONS IN THE CEREBROSPINAL FLUID.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Intrathecal enzyme replacement therapy for mucopolysaccharidosis I: translating success in animal models to patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Froin's syndrome revisited, 100 years on. Pseudo-Froin's syndrome on MRI.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Central nervous system therapy for lysosomal storage disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

The challenge of drug-induced aseptic meningitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Acute painful lumbosacral paresthesia after intrathecal rituximab

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Enzyme-replacement therapy in mucopolysaccharidosis I.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855632

Cervical cord compression in mucopolysaccharidosis

2 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Cervical myelopathy due to dural compression in mucopolysaccharidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Drug-induced aseptic meningitis in suspected central nervous system infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2013.158

IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24002329

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PR.2013.158

1 reference

20 August 2017

1 reference

20 August 2017

1 reference